News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

National throws a lifeline to 300 women

9 December 2008


National throws a lifeline to 300 women


The New Zealand Breast Cancer Foundation (NZBCF) is relieved that 300 New Zealand women each year with HER2 positive early breast cancer will now have a 12 month course of Herceptin fully funded through the public health service if their clinician recommends it. The funding for the 12 month course applies from November 19.

Minister of Health, Tony Ryall announced today that the National Government now has a contract with the drug supplier Roche and will provide an additional $9 million per year to District Health Boards to be ring-fenced for 12 month courses of Herceptin.

Dr Belinda Scott, breast surgeon and Chair of The New Zealand Breast Cancer Foundation’s Medical Advisory Committee, says that the extended Herceptin funding is fantastic news for women with HER2 positive early stage breast cancer, their families and the New Zealand community.

“The bulk of scientific data overwhelmingly supports a 12 month course of Herceptin for those breast cancers for which it is effective. This decision enables clinicians to recommend the 12 month course for those patients they believe it will help without the financial implications that this decision has previously raised” she says.

The Foundation’s Executive Trustee, Heather Shotter is praising the Government’s prioritizing of the Herceptin issue. “Families all over New Zealand have had to mortgage their homes or raise other forms of debt to afford to save the life of a mother, daughter, sister or wife. You can’t put a price on the lives of New Zealand women - the decision to fund a 12 month course of Herceptin means that we don’t have to”.

Breast cancer was the leading cause of death from cancer among females in 2005 (647deaths or 17.1 percent of female cancer deaths), according to the latest statistics available from the Ministry of Health. “HER2 positive breast cancer accounts for around 20 – 25% of those cancers diagnosed or approximately 320 patients per year at a conservative estimate” Dr Scott says.

The New Zealand Breast Cancer Foundation will continue to support and review all new data on Herceptin and other breast cancer drug treatments as the information becomes available through clinical trials and from the New Zealand

Breast Cancer Patient Registers which The Foundation is rolling out with District Health Boards around New Zealand.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Review: A Rose By Any Other Name Would Smell As Sweet

The Royal New Zealand Ballet has accepted the challenge of this heart-touching tragedy and largely succeeded. More>>

ALSO:

NZ's First Male IAAF Gold: Tom Walsh's Historic Shot Put Victory

Although feeling very sore but with a great feeling Tom Walsh took his place as number one on the victory dais to receive his much deserved gold medal. More>>

ALSO:

Scoop Review Of Books: Q&A: Hard To Find Books

"Unfortunately we are in crisis and this friendly dinosaur faces extinction… Our only hope is to try and raise funds to buy the building and restore it to its glory, either fully funded or with a viable deposit." More>>

Kid Lit: Lost Mansfield Story Discovered At Wellington Library

Previously undiscovered letters and a story written by a young Katherine Mansfield were recently unearthed in Wellington City Library’s archives by a local author researching a book about the famous writer. More>>

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland